<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: An 8-year retrospective study was conducted to evaluate the prevalence and the classification of canine <z:e sem="disease" ids="C0005956" disease_type="Disease or Syndrome" abbrv="">bone marrow disorders</z:e> in a clinical pathology service at a university referral hospital </plain></SENT>
<SENT sid="1" pm="."><plain>ANIMALS: Dogs evaluated for <z:e sem="disease" ids="C0005956" disease_type="Disease or Syndrome" abbrv="">bone marrow disorders</z:e> at a veterinary teaching hospital </plain></SENT>
<SENT sid="2" pm="."><plain>HYPOTHESIS: A better understanding of the spectrum and the prevalence of canine <z:e sem="disease" ids="C0005956" disease_type="Disease or Syndrome" abbrv="">bone marrow disorders</z:e> can be achieved with a multiyear retrospective study </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Bone marrow aspirate smears, core biopsy specimens, and case records from 717 dogs were reviewed </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Bone marrow specimens were first categorized based on the presence or the absence of a primary <z:e sem="disease" ids="C0005956" disease_type="Disease or Syndrome" abbrv="">bone marrow disorder</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Nondysplastic and nonmalignant pathologic changes were placed into 14 subcategories </plain></SENT>
<SENT sid="6" pm="."><plain>Frequently observed pathologic disorders included nonregenerative immune-mediated <z:hpo ids='HP_0001903'>anemia</z:hpo>, pure red cell <z:mpath ids='MPATH_58'>aplasia</z:mpath>, bone marrow <z:mp ids='MP_0001651'>necrosis</z:mp>, <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo>, and <z:mpath ids='MPATH_654'>hemophagocytic syndrome</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0026986" disease_type="Neoplastic Process" abbrv="MDS">Dysmyelopoiesis</z:e> (n = 61) was subcategorized into <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (n = 27), and congenital (n = 1) and secondary (n = 33) <z:e sem="disease" ids="C0026986" disease_type="Neoplastic Process" abbrv="MDS">dysmyelopoiesis</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>One hundred twenty-six cases of <z:hpo ids='HP_0002664'>neoplasia</z:hpo> were divided into <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> (n = 46), <z:hpo ids='HP_0005558'>chronic leukemia</z:hpo> (n = 7), stage 5 malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 28), <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> (n = 25), malignant <z:mpath ids='MPATH_146,MPATH_652'>histiocytosis</z:mpath> (n = 11), metastatic <z:mpath ids='MPATH_349'>mast-cell tumor</z:mpath> (n = 3), <z:hpo ids='HP_0100242'>sarcoma</z:hpo> (n = 5), and <z:mp ids='MP_0002038'>carcinoma</z:mp> (n = 1) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS AND CLINICAL IMPORTANCE: This study provides a general indication of the spectrum and the prevalence of canine <z:e sem="disease" ids="C0005956" disease_type="Disease or Syndrome" abbrv="">bone marrow disorders</z:e> at a referral center in North America </plain></SENT>
</text></document>